122 related articles for article (PubMed ID: 18621018)
1. Oxidative stress causes membrane phospholipid rearrangement and shedding from RBC membranes--an NMR study.
Freikman I; Amer J; Cohen JS; Ringel I; Fibach E
Biochim Biophys Acta; 2008 Oct; 1778(10):2388-94. PubMed ID: 18621018
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress-induced membrane shedding from RBCs is Ca flux-mediated and affects membrane lipid composition.
Freikman I; Ringel I; Fibach E
J Membr Biol; 2011 Mar; 240(2):73-82. PubMed ID: 21259001
[TBL] [Abstract][Full Text] [Related]
3. Membrane phospholipid asymmetry in human thalassemia.
Kuypers FA; Yuan J; Lewis RA; Snyder LM; Kiefer CR; Bunyaratvej A; Fucharoen S; Ma L; Styles L; de Jong K; Schrier SL
Blood; 1998 Apr; 91(8):3044-51. PubMed ID: 9531618
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid composition and organization in model beta-thalassemic erythrocytes.
Kuypers FA; Schott MA; Scott MD
Am J Hematol; 1996 Jan; 51(1):45-54. PubMed ID: 8571937
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte phosphatidylserine exposure in β-thalassemia.
Ibrahim HA; Fouda MI; Yahya RS; Abousamra NK; Abd Elazim RA
Lab Hematol; 2014 Jun; 20(2):9-14. PubMed ID: 25000947
[TBL] [Abstract][Full Text] [Related]
6. Cytoskeletal protein binding kinetics at planar phospholipid membranes.
Mc Kiernan AE; MacDonald RI; MacDonald RC; Axelrod D
Biophys J; 1997 Oct; 73(4):1987-98. PubMed ID: 9336194
[TBL] [Abstract][Full Text] [Related]
7. Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo.
Shalev O; Repka T; Goldfarb A; Grinberg L; Abrahamov A; Olivieri NF; Rachmilewitz EA; Hebbel RP
Blood; 1995 Sep; 86(5):2008-13. PubMed ID: 7655028
[TBL] [Abstract][Full Text] [Related]
8. A flow cytometry approach for quantitative analysis of cellular phosphatidylserine distribution and shedding.
Freikman I; Amer J; Ringel I; Fibach E
Anal Biochem; 2009 Oct; 393(1):111-6. PubMed ID: 19531362
[TBL] [Abstract][Full Text] [Related]
9. Shedding of phosphatidylserine from developing erythroid cells involves microtubule depolymerization and affects membrane lipid composition.
Freikman I; Ringel I; Fibach E
J Membr Biol; 2012 Dec; 245(12):779-87. PubMed ID: 22825717
[TBL] [Abstract][Full Text] [Related]
10. Oxidative status of platelets in normal and thalassemic blood.
Amer J; Fibach E
Thromb Haemost; 2004 Nov; 92(5):1052-9. PubMed ID: 15543333
[TBL] [Abstract][Full Text] [Related]
11. Distribution and shedding of the membrane phosphatidylserine during maturation and aging of erythroid cells.
Freikman I; Fibach E
Biochim Biophys Acta; 2011 Dec; 1808(12):2773-80. PubMed ID: 21871434
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol-loading of membranes of normal erythrocytes inhibits phospholipid repair and arachidonoyl-CoA:1-palmitoyl-sn-glycero-3-phosphocholine acyl transferase. A model of spur cell anemia.
Allen DW; Manning N
Blood; 1996 Apr; 87(8):3489-93. PubMed ID: 8605368
[TBL] [Abstract][Full Text] [Related]
13. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes.
Schwartz RS; Tanaka Y; Fidler IJ; Chiu DT; Lubin B; Schroit AJ
J Clin Invest; 1985 Jun; 75(6):1965-72. PubMed ID: 4008648
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure.
Kean LS; Brown LE; Nichols JW; Mohandas N; Archer DR; Hsu LL
Exp Hematol; 2002 May; 30(5):394-402. PubMed ID: 12031645
[TBL] [Abstract][Full Text] [Related]
15. Effects of phosphatidylinositol diphosphate on phospholipid asymmetry in the human erythrocyte membrane.
Shiffer KA; Rood L; Emerson RK; Kuypers FA
Biochemistry; 1998 Mar; 37(10):3449-58. PubMed ID: 9521666
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E.
Das N; Das Chowdhury T; Chattopadhyay A; Datta AG
Pol J Pharmacol; 2004; 56(1):85-96. PubMed ID: 15047982
[TBL] [Abstract][Full Text] [Related]
17. Human erythrocyte protein 4.1 is a phosphatidylserine binding protein.
Rybicki AC; Heath R; Lubin B; Schwartz RS
J Clin Invest; 1988 Jan; 81(1):255-60. PubMed ID: 3335640
[TBL] [Abstract][Full Text] [Related]
18. Erythrocytic phosphatidylserine exposure and hemostatic alterations in β-thalassemia intermediate patients.
Zahedpanah M; Azarkeivan A; Aghaieepour M; Nikogoftar M; Ahmadinegad M; Hajibeigi B; Tabatabaiee MR; Maghsudlu M
Hematology; 2014 Dec; 19(8):472-6. PubMed ID: 24620948
[TBL] [Abstract][Full Text] [Related]
19. Effect of lead on lipid peroxidation, phospholipids composition, and methylation in erythrocyte of human.
Shafiq-ur-Rehman
Biol Trace Elem Res; 2013 Sep; 154(3):433-9. PubMed ID: 23846836
[TBL] [Abstract][Full Text] [Related]
20. The cholesterol content of the erythrocyte membrane is an important determinant of phosphatidylserine exposure.
van Zwieten R; Bochem AE; Hilarius PM; van Bruggen R; Bergkamp F; Hovingh GK; Verhoeven AJ
Biochim Biophys Acta; 2012 Dec; 1821(12):1493-500. PubMed ID: 22960544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
